050sek
-17,0 %
Date:2024-06-19Time:17:08:44Latest report:Q4-2023List:First NorthTicker:2CUREX
Market Cap:13 msekEnterprise Value:-1 msekNet Sales:0,16 msekEarnings:-30,8 msekEmployees:0ISIN:SE0010468124

Ratios

10-year key figure history for 2cureX turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for 2cureX with index and moving average MA50 and MA200.

Stockprice:0,50
MA50:0,38
MA200:1,73
Price/MA200:-71,3 %
RSI (14):68,1
Price/MA50:31,5 %

Description

2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

Medical Equipment